• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Systemic absorption of intrathecal methotrexate.鞘内注射甲氨蝶呤的全身吸收。
BMJ Case Rep. 2023 Apr 18;16(4):e254027. doi: 10.1136/bcr-2022-254027.
2
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.乳腺癌软脑膜转移:联合治疗的结果以及甲氨蝶呤和脂质体阿糖胞苷作为脑脊液化疗药物的比较
Clin Breast Cancer. 2015 Feb;15(1):66-72. doi: 10.1016/j.clbc.2014.07.004. Epub 2014 Aug 22.
3
Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.同步放疗联合鞘内注射甲氨蝶呤治疗具有不良预后因素的实体瘤软脑膜转移:一项前瞻性单臂研究。
Int J Cancer. 2016 Oct 15;139(8):1864-72. doi: 10.1002/ijc.30214. Epub 2016 Jun 30.
4
Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.鞘内注射曲妥珠单抗(赫赛汀)和甲氨蝶呤治疗HER2过表达转移性乳腺癌脑膜癌病:一例报告
Anticancer Drugs. 2008 Sep;19(8):832-6. doi: 10.1097/CAD.0b013e32830b58b0.
5
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.乳腺癌患者的脑膜癌病。临床特征、预后因素及大剂量鞘内注射甲氨蝶呤方案的结果
Cancer. 1996 Apr 1;77(7):1315-23. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4.
6
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.接受鞘内曲妥珠单抗、鞘内化疗或全脑放疗治疗的乳腺软脑膜疾病的临床结局。
Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11.
7
[Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer].[鞘内化疗用于乳腺癌患者软脑膜转移]
Zh Vopr Neirokhir Im N N Burdenko. 2024;88(3):31-37. doi: 10.17116/neiro20248803131.
8
Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.乳腺癌脑膜转移患者鞘内注射曲妥珠单抗联合阿糖胞苷和甲氨蝶呤。
Breast. 2011 Oct;20(5):478-80. doi: 10.1016/j.breast.2011.05.007. Epub 2011 Jun 23.
9
Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.乳腺癌所致癌性脑膜炎的鞘内化疗
Anticancer Res. 2002 Sep-Oct;22(5):3057-9.
10
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.鞘内注射曲妥珠单抗(赫赛汀商标)在治疗HER2过表达转移性乳腺癌脑膜癌病中的应用。
Oncol Rep. 2006 May;15(5):1373-7. doi: 10.3892/or.15.5.1373.

引用本文的文献

1
Methotrexate-induced epidermal necrosis following intrathecal chemotherapy: A case report.鞘内化疗后甲氨蝶呤诱导的表皮坏死:一例报告。
JAAD Case Rep. 2024 Dec 14;56:107-110. doi: 10.1016/j.jdcr.2024.12.005. eCollection 2025 Feb.

本文引用的文献

1
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan.曲妥珠单抗-德鲁替康治疗多灶性和经病理证实的脑转移完全缓解。
CNS Oncol. 2022 Sep 1;11(3):CNS90. doi: 10.2217/cns-2022-0010. Epub 2022 Jun 8.
2
Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study.鞘内不同剂量甲氨蝶呤治疗脑膜转移瘤的临床疗效和安全性:一项前瞻性、单臂研究。
Jpn J Clin Oncol. 2021 Dec 1;51(12):1715-1722. doi: 10.1093/jjco/hyab155.
3
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood-Brain Barrier.脑转移瘤的治疗:酪氨酸激酶抑制剂的地位以及如何促进其穿过血脑屏障
Pharmaceutics. 2021 Sep 10;13(9):1446. doi: 10.3390/pharmaceutics13091446.
4
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.CDK4/6 抑制剂在乳腺癌治疗中的作用:与药物、基因和病理生理状况的潜在相互作用。
Int J Mol Sci. 2020 Sep 1;21(17):6350. doi: 10.3390/ijms21176350.
5
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.脑肿瘤和转移瘤中的血脑屏障和血肿瘤屏障。
Nat Rev Cancer. 2020 Jan;20(1):26-41. doi: 10.1038/s41568-019-0205-x. Epub 2019 Oct 10.
6
Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.接受两线鞘内化疗的乳腺癌软脑膜转移——病例报告
Klin Onkol. 2019 Spring;32(2):139-142. doi: 10.14735/amko2018139.
7
Leptomeningeal carcinomatosis in patients with breast cancer.乳腺癌患者的脑膜转移癌。
Crit Rev Oncol Hematol. 2019 Mar;135:85-94. doi: 10.1016/j.critrevonc.2019.01.020. Epub 2019 Feb 1.
8
The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.鞘内化疗治疗乳腺癌软脑膜转移患者的必要性:一项系统评价和汇总分析。
Curr Probl Cancer. 2017 Sep-Oct;41(5):355-370. doi: 10.1016/j.currproblcancer.2017.07.001. Epub 2017 Jul 12.
9
Death and Neurological Devastation From Intrathecal Vinca Alkaloids.鞘内注射长春花生物碱导致的死亡和神经功能损害
P T. 2016 Aug;41(8):464-525.
10
Preventing and Managing Toxicities of High-Dose Methotrexate.预防和管理大剂量甲氨蝶呤的毒性反应
Oncologist. 2016 Dec;21(12):1471-1482. doi: 10.1634/theoncologist.2015-0164. Epub 2016 Aug 5.

鞘内注射甲氨蝶呤的全身吸收。

Systemic absorption of intrathecal methotrexate.

机构信息

Department of Medicine, University of Florida, Gainesville, Florida, USA

Department of Medicine, Division of Hematology and Oncology, University of Florida, Gainesville, Florida, USA.

出版信息

BMJ Case Rep. 2023 Apr 18;16(4):e254027. doi: 10.1136/bcr-2022-254027.

DOI:10.1136/bcr-2022-254027
PMID:37072302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10124216/
Abstract

Leptomeningeal spread of cancer is rare, difficult to both diagnostically confirm and treat, and associated with a poor prognosis. The blood-brain barrier largely prevents sufficient penetration of systemic therapy to be effective. Direct administration of intrathecal therapy has thus been used as an alternative treatment option. We present a case of breast cancer complicated by leptomeningeal spread. Intrathecal methotrexate was initiated, and the manifestation of systemic side effects suggested systemic absorption. This was subsequently confirmed by blood work showing detectable methotrexate levels following intrathecal administration as well as resolution of symptoms with reduction in the dose of methotrexate administered.

摘要

癌症的脑膜转移较为罕见,在诊断和治疗上都极具挑战性,且预后较差。血脑屏障极大地阻止了全身治疗药物的充分渗透,使其难以发挥作用。因此,人们采用鞘内治疗作为替代治疗方案。我们报告了一例乳腺癌合并脑膜转移的病例。给予患者鞘内注射甲氨蝶呤,全身不良反应的出现提示药物已被全身吸收。这随后通过血液检查得到证实,即鞘内给药后可检测到甲氨蝶呤水平,且随着甲氨蝶呤剂量的减少,症状也得到了缓解。